TOMS RIVER, NJ — The Toms River Police Department is urgently requesting public assistance to locate Elaine Dicataldo, an Alzheimer’s patient who went missing earlier today. Elaine drove away from…
(Reuters) – Biogen Inc said on Wednesday it would terminate a post-approval study of its first Alzheimer’s drug, Aduhelm, and discontinue all commercialization for the controversial treatment. The strategic shift…
By Julie Steenhuysen CHICAGO (Reuters) – Breakthrough Alzheimer’s treatments that remove toxic proteins from the brain have revived interest in vaccines to treat the memory-robbing disease, potentially offering a cheaper,…
By Deena Beasley (Reuters) – Blood tests for Alzheimer’s are needed to more widely diagnose the brain-wasting disease and understand its prevalence, but it will be another couple of years…
By Julie Steenhuysen CHICAGO (Reuters) – When Lianor da Cunha Hillerstrom of Lexington, Massachusetts, learned her now 9-year-old son Oskar had Down syndrome, she was concerned but not panicked. As…
NEWARK, NJ – Newark Public Safety Director Fritz G. Fragé has issued an urgent appeal to the public for assistance in locating 70-year-old Errol Bryan, who was reported missing on…
By Julie Steenhuysen and Deena Beasley CHICAGO (Reuters) – Five major U.S. health systems said they would offer Eisai and Biogen’s promising new Alzheimer’s drug Leqembi after working out payment…
(Reuters) – Eisai Co Ltd and Biogen Inc’s Leqembi emerged as the first Alzheimer’s treatment to win the U.S. Food and Drug Administration’s standard approval on Thursday, a milestone in…
By Deena Beasley The U.S. Food and Drug Administration on Thursday granted standard approval to Eisai and Biogen’s Leqembi for patients with Alzheimer’s disease. The FDA decision is expected to…
By Julie Steenhuysen CHICAGO (Reuters) -The U.S. Medicare health plan on Thursday offered details of plans to collect patient data as a condition for reimbursement for Eisai Co Ltd and…
By Natalie Grover LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a darling of celebrities and investors, are being studied to tackle…
By Deena Beasley and Julie Steenhuysen (Reuters) – Eli Lilly and Co expects the U.S. Medicare health plan to back down from strict coverage limits on new Alzheimer’s drugs as…
JAMES CARTER AND JAMES PINKERTON: There’s A Major Obstacle To Finding The Cure For Alzheimer’s James Carter And James Pinkerton on March 4, 2023 Three years ago, one of us…
(Reuters) – The $26,500-per-year price tag for Eisai Co Ltd and Biogen Inc’s newly approved Alzheimer’s disease drug is slightly above expectations, but should not dent demand for the promising…
(Reuters) – Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the U.S. Food and Drug Administration for a standard review of its Alzheimer’s drug…
(Reuters) – The U.S. Food and Drug Administration on Friday approved Eisai Co Ltd and Biogen Inc’s Alzheimer’s drug lecanemab for the treatment of early forms of the fatal, brain-wasting…
By Julie Steenhuysen CHICAGO (Reuters) – Swiss drugmaker Roche is closing down most clinical trials of its experimental Alzheimer’s drug gantenerumab after it failed to slow advance of the mind-robbing…
By Deena Beasley and Julie Steenhuysen SAN FRANCISCO (Reuters) – Japan’s Eisai Co plans to seek full approval of its experimental Alzheimer’s drug lecanemab in the United States, Europe and…
By Julie Steenhuysen CHICAGO (Reuters) -The first big breakthrough in 30 years of Alzheimer’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark proteins associated…
By Newark PD, Newark Public Safety Director Fritz G. Fragé seeks the public’s help in locating Rafael Rivera, 73, who was reported missing today, Friday, November 4, 2022. Mr. Rivera,…
By Julie Steenhuysen CHICAGO (Reuters) – Clear evidence this week that Eisai and Biogen’s drug lecanemab slows cognitive decline in early stage dementia has galvanized efforts among Alzheimer’s researchers toward…
NEWARK, NJ – Police in Newark have issued a silver alert for a missing 83-year-old man named Felix Perez, who went missing earlier in the day. “Mr. Perez, who suffers…
(Reuters) – Biogen said on Tuesday its Chief Executive Michel Vounatsos will step down, with the drugmaker adding it would scale down its sales infrastructure for the controversial Alzheimer’s drug…
By Deena Beasley – Patient groups are mounting a public pressure campaign aimed at persuading the U.S. government to loosen proposed restrictions on new Alzheimer’s treatments, spending millions of dollars…
Biogen, and its Japanese partner Eisai, announced Monday that it plans to begin the process for U.S. approval for its experimental drug for Alzheimer’s. Biogen and Eisai announced “rolling submission”…